Second, the studies had differences in the baseline BNP or NT-pro-BNP values in patients with T2DM and in whether they had received cardiovascular therapy, which also could have had an effect on the pooled analysis. The gene discussed is NPPB; the disease is type 2 diabetes mellitus.